Oct. 7, 2008 - DIAGNOS inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence ("AI") and advanced knowledge extraction techniques, launches CARA (Computer Aided Retinal Analysis) application bringing to market an 18 month development effort. CARA is an automated system for the identification of diabetic retinopathy and other eye related pathologies."I am very pleased to announce this new development based on our Artificial Intelligence platform. The software will be used for screening patients in hospitals, as well as private and public clinics and practices. The World Health Organization estimates that by year 2030, 366,000,000 people will have diabetes. DIAGNOS' goal is to provide our open platform analysis tool, to expand the diagnostic capabilities of more than 200,000 digital retinal imaging systems which currently exist worldwide... [PDF] DIAGNOS' Press Release -
